Clinical trial
A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not…
NCT00081900 · Genzyme, a Sanofi Company, Industry · Terminated
Key facts
| NCT number | NCT00081900 |
|---|---|
| Title | A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care |
| Official title | A Phase 1/2 Study of DENSPM (N1, N11-diethylnorspermine) in Patients With Unresectable Hepatocellular Carcinoma |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Hepatocellular |
| Intervention type | Drug |
| Interventions | DENSPM ) |
| Enrollment | 38 |
| Start date | Mar 1, 2004 |
| Primary completion | Jul 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Apr 28, 2004 |
| Last update posted | Apr 13, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: